Advaxis is a biotechnology company based in North Brunswick and Princeton , New Jersey which develops Listeria cancer vaccines.
Advaxis uses live genetically modified Listeria monocytogenes to treat cancers, infectious disease and problems of the immune system. With a total of over 10 years of innovative work conducted by Yvonne Paterson, Ph.D., Professor of Microbiology at the University of Pennsylvania, discoveries uncovered the unique capabili...
more
Advaxis is a biotechnology company based in North Brunswick and Princeton , New Jersey which develops Listeria cancer vaccines.
Advaxis uses live genetically modified Listeria monocytogenes to treat cancers, infectious disease and problems of the immune system. With a total of over 10 years of innovative work conducted by Yvonne Paterson, Ph.D., Professor of Microbiology at the University of Pennsylvania, discoveries uncovered the unique capabilities of microbe Listeria. The microbe promotes simultaneous stimulatation of every aspect within the immune system creating a process for coordinating innate, humoral [antibodies|antibody] and encourages cellular adaptive immune responses in an extremely effective response to existing cancers and other diseases.
Advaxis is the exclusive licensee of a patented broadly enabling Listeria platform technology that can elicit effective anti-tumor responses. The leading Advaxis Listeria vaccine candidate, Lovaxin C, targets cervical cancer and...
less